BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 30804928)

  • 21. A missing PD-L1/PD-1 coinhibition regulates diabetes induction by preproinsulin-specific CD8 T-cells in an epitope-specific manner.
    Schuster C; Brosi H; Stifter K; Boehm BO; Schirmbeck R
    PLoS One; 2013; 8(8):e71746. PubMed ID: 23977133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The PD-1: PD-L1 pathway promotes development of brain-resident memory T cells following acute viral encephalitis.
    Prasad S; Hu S; Sheng WS; Chauhan P; Singh A; Lokensgard JR
    J Neuroinflammation; 2017 Apr; 14(1):82. PubMed ID: 28407741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PD-1 signaling in neonates restrains CD8
    Eddens T; Parks OB; Zhang Y; Manni ML; Casanova JL; Ogishi M; Williams JV
    Mucosal Immunol; 2024 Jun; 17(3):476-490. PubMed ID: 38176655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor PD-L1 co-stimulates primary human CD8(+) cytotoxic T cells modified to express a PD1:CD28 chimeric receptor.
    Prosser ME; Brown CE; Shami AF; Forman SJ; Jensen MC
    Mol Immunol; 2012 Jul; 51(3-4):263-72. PubMed ID: 22503210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The regulatory T-cell response during acute retroviral infection is locally defined and controls the magnitude and duration of the virus-specific cytotoxic T-cell response.
    Zelinskyy G; Dietze KK; Hüsecken YP; Schimmer S; Nair S; Werner T; Gibbert K; Kershaw O; Gruber AD; Sparwasser T; Dittmer U
    Blood; 2009 Oct; 114(15):3199-207. PubMed ID: 19671923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B7-H3 Negatively Modulates CTL-Mediated Cancer Immunity.
    Yonesaka K; Haratani K; Takamura S; Sakai H; Kato R; Takegawa N; Takahama T; Tanaka K; Hayashi H; Takeda M; Kato S; Maenishi O; Sakai K; Chiba Y; Okabe T; Kudo K; Hasegawa Y; Kaneda H; Yamato M; Hirotani K; Miyazawa M; Nishio K; Nakagawa K
    Clin Cancer Res; 2018 Jun; 24(11):2653-2664. PubMed ID: 29530936
    [No Abstract]   [Full Text] [Related]  

  • 27. The level of friend retrovirus replication determines the cytolytic pathway of CD8+ T-cell-mediated pathogen control.
    Zelinskyy G; Balkow S; Schimmer S; Werner T; Simon MM; Dittmer U
    J Virol; 2007 Nov; 81(21):11881-90. PubMed ID: 17728236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Costimulatory molecule programmed death-1 in the cytotoxic response during chronic hepatitis C.
    Larrubia JR; Benito-Martínez S; Miquel J; Calvino M; Sanz-de-Villalobos E; Parra-Cid T
    World J Gastroenterol; 2009 Nov; 15(41):5129-40. PubMed ID: 19891011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TLR ligand induced IL-6 counter-regulates the anti-viral CD8(+) T cell response during an acute retrovirus infection.
    Wu W; Dietze KK; Gibbert K; Lang KS; Trilling M; Yan H; Wu J; Yang D; Lu M; Roggendorf M; Dittmer U; Liu J
    Sci Rep; 2015 May; 5():10501. PubMed ID: 25994622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A potential new pathway for PD-L1 costimulation of the CD8-T cell response to Listeria monocytogenes infection.
    Xu D; Fu HH; Obar JJ; Park JJ; Tamada K; Yagita H; Lefrançois L
    PLoS One; 2013; 8(2):e56539. PubMed ID: 23409193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Role of programmed death-1 in viral infectious diseases].
    Lu FC; Nong GM
    Zhongguo Dang Dai Er Ke Za Zhi; 2018 Jan; 20(1):77-82. PubMed ID: 29335088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Granulocytic myeloid-derived suppressor cells suppress virus-specific CD8
    Drabczyk-Pluta M; Werner T; Hoffmann D; Leng Q; Chen L; Dittmer U; Zelinskyy G
    Retrovirology; 2017 Aug; 14(1):42. PubMed ID: 28835242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type 1 interferon-induced IL-7 maintains CD8+ T-cell responses and homeostasis by suppressing PD-1 expression in viral hepatitis.
    Hou L; Jie Z; Liang Y; Desai M; Soong L; Sun J
    Cell Mol Immunol; 2015 Mar; 12(2):213-21. PubMed ID: 25027969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice.
    Frebel H; Nindl V; Schuepbach RA; Braunschweiler T; Richter K; Vogel J; Wagner CA; Loffing-Cueni D; Kurrer M; Ludewig B; Oxenius A
    J Exp Med; 2012 Dec; 209(13):2485-99. PubMed ID: 23230000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fas Ligand-mediated cytotoxicity of CD4+ T cells during chronic retrovirus infection.
    Malyshkina A; Littwitz-Salomon E; Sutter K; Zelinskyy G; Windmann S; Schimmer S; Paschen A; Streeck H; Hasenkrug KJ; Dittmer U
    Sci Rep; 2017 Aug; 7(1):7785. PubMed ID: 28798348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination immunotherapy with anti-PD-L1 antibody and depletion of regulatory T cells during acute viral infections results in improved virus control but lethal immunopathology.
    David P; Drabczyk-Pluta M; Pastille E; Knuschke T; Werner T; Honke N; Megger DA; Akhmetzyanova I; Shaabani N; Eyking-Singer A; Cario E; Kershaw O; Gruber AD; Tenbusch M; Dietze KK; Trilling M; Liu J; Schadendorf D; Streeck H; Lang KS; Xie Y; Zimmer L; Sitek B; Paschen A; Westendorf AM; Dittmer U; Zelinskyy G
    PLoS Pathog; 2020 Mar; 16(3):e1008340. PubMed ID: 32226027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PD-1 upregulated on regulatory T cells during chronic virus infection enhances the suppression of CD8+ T cell immune response via the interaction with PD-L1 expressed on CD8+ T cells.
    Park HJ; Park JS; Jeong YH; Son J; Ban YH; Lee BH; Chen L; Chang J; Chung DH; Choi I; Ha SJ
    J Immunol; 2015 Jun; 194(12):5801-11. PubMed ID: 25934860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD4+ T cells develop antiretroviral cytotoxic activity in the absence of regulatory T cells and CD8+ T cells.
    Manzke N; Akhmetzyanova I; Hasenkrug KJ; Trilling M; Zelinskyy G; Dittmer U
    J Virol; 2013 Jun; 87(11):6306-13. PubMed ID: 23536666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality.
    Saha A; O'Connor RS; Thangavelu G; Lovitch SB; Dandamudi DB; Wilson CB; Vincent BG; Tkachev V; Pawlicki JM; Furlan SN; Kean LS; Aoyama K; Taylor PA; Panoskaltsis-Mortari A; Foncea R; Ranganathan P; Devine SM; Burrill JS; Guo L; Sacristan C; Snyder NW; Blair IA; Milone MC; Dustin ML; Riley JL; Bernlohr DA; Murphy WJ; Fife BT; Munn DH; Miller JS; Serody JS; Freeman GJ; Sharpe AH; Turka LA; Blazar BR
    J Clin Invest; 2016 Jul; 126(7):2642-60. PubMed ID: 27294527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
    J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.